1. Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes. Issue 2 (March 2015) Authors: Turecek, Peter L; Abbühl, Brigitt; Tangada, Srilatha D; Chapman, Miranda; Gritsch, Herbert; Rottensteiner, Hanspeter; Schrenk, Gerald; Mitterer, Artur; Dietrich, Barbara; Höllriegl, Werner; Schiviz, Alexandra; Horling, Frank; Reipert, Birgit M; Muchitsch, Eva-Maria; Pavlova, Borislava G; Scheifli... Journal: Expert review of clinical pharmacology Issue: Volume 8:Issue 2(2015) Page Start: 163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B. (19th August 2020) Authors: Windyga, Jerzy; Timofeeva, Margarita; Stasyshyn, Oleksandra; Mamonov, Vasily; Lamas Castellanos, José Luis; Lissitchkov, Toshko; Chojnowski, Krzysztof; Chapman, Miranda; Pavlova, Borislava G.; Tangada, Srilatha Journal: Clinical and applied thrombosis/hemostasis Issue: Volume 26(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗